 |
 |
|
PAPERS / TUMOR MARKERS All listed papers describe results obtained with DIATHEVA's products. Share with us your results sending your next pubblications with our products at info@diatheva.com
 ”The expression and modulation of CEACAM1 and tumor cell transformation.”Ann Ist Super Sanita. 2012;48(2):161-71.DOI: 10.4415/ANN_12_02_09. ”CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors”Open Pharmacology Journal 2012 ”Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein”BMC Cancer, 6:41 (2006) |
MORE PAPERS
BROCHURES and APPLICATION GUIDES
|
